Disparities in healthcare access have been a well-documented problem in the USA [
1]. Despite significant advancements in healthcare technology and the potential for improved patient outcomes, access to quality care remains inequitable and uneven across populations. Access to Metabolic and Bariatric Surgery (MBS), the most effective therapy for achieving sustained weight loss for severely obese, is no exception. In fact, less than 1% of eligible patients suffering from severe obesity undergo the lifesaving treatment of MBS [
2]. While this discordance in appropriate treatment is multifactorial, several variables such as gender, race, insurance coverage, level of education, and socioeconomical factors have been correlated with poor access to MBS. In addition, previous studies have demonstrated that patient’s geographic location also influences MBS outcomes [
3]. Data collected from four academic centers in the Chicagoland area revealed similar patterns of poor access to care. …
